Lackner Mark was granted 141,000 shares and sold $18,291 worth of shares (1,585 units at $11.54), increasing direct ownership by 248% to 195,728 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

ZNTL· Zentalis Pharmaceuticals Inc.

Health Care

Original source

Lackner Mark was granted 141,000 shares and sold $18,291 worth of shares (1,585 units at $11.54), increasing direct ownership by 248% to 195,728 units (SEC Form 4) | Quantisnow